Capturing circulating tumor cells of hepatocellular carcinoma

被引：53
|
作者：
Wu, Li-Jun [2 ]
Pan, Yi-Da [2 ]
Pei, Xiao-Yu [2 ]
Chen, Hong [3 ]
Nguyen, Samantha [4 ]
Kashyap, Akshay [4 ]
Liu, Jie [1 ,2 ]
Wu, Jian [2 ,4 ,5 ]
机构：
[1] Fudan Univ, Huashan Hosp, Inst Digest Dis, Dept Digest Dis, Shanghai 210040, Peoples R China
[2] Fudan Univ, Inst Digest Dis, Shanghai 210040, Peoples R China
[3] Southeast Univ, Coll Med, Dept Gastroenterol & Hepatol, Nanjing 210009, Jiangsu, Peoples R China
[4] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Sacramento, CA 95817 USA
[5] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
来源：
CANCER LETTERS | 2012年 / 326卷 / 01期
关键词：
Circulating tumor cells; Hepatocellular carcinoma; Cancer stem cells; Tumor self-seeding; HCC thrombus formation in the portal vein; CANCER STEM-CELLS; LIVER-TRANSPLANTATION; IDENTIFICATION; BLOOD; METASTASIS; RECURRENCE; EXPRESSION; SIZE;
D O I：
10.1016/j.canlet.2012.07.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Early metastases of hepatocellular carcinoma (HCC) may be detected by the isolation of circulating tumor cells (CTCs) in the bloodstream. During the course of therapeutic attempts, monitoring CTC changes in patients with HCC is helpful for the efficacy assessment. Nevertheless, the markers used for the detection, such as alpha-feto protein, asialoglycoprotein receptor or epithelial cell adhesion molecule, CD133 or CD90, are not specific for HCC CTCs. In spite of these limitations, a timely determination of the existence of CTCs will be beneficial for the monitoring of distant metastases, the evaluation of therapeutic attempts, and the prediction of prognosis. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：17 / 22
页数：6
相关论文
共 50 条
  • [11] Capturing and releasing of hepatocellular carcinoma EpCAM plus and EpCAM- circulating tumor cells based on photosensitive intelligent nanoreactor
    Mao, Zhifang
    Hu, Meng
    Shen, Qinglin
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 12
  • [12] Circulating tumor DNA/circulating tumor cells and the applicability in different causes induced hepatocellular carcinoma
    Li, Xuemei
    Wang, Huihui
    Li, Tao
    Wang, Lianzi
    Wu, Xian
    Liu, Jiaqing
    Xu, Yuanhong
    Wei, Wei
    [J]. CURRENT PROBLEMS IN CANCER, 2020, 44 (02)
  • [13] Radiomics and circulating tumor cells: personalized care in hepatocellular carcinoma?
    Hesketh, Richard L.
    Zhu, Andrew X.
    Oklu, Rahmi
    [J]. DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2015, 21 (01) : 78 - 84
  • [14] CIRCULATING TUMOR CELLS; A PROGNOSTIC BIOMARKER IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Prasoppokakorn, Thaninee
    Buntho, Areeya
    Ingrungruanglert, Praewphan
    Israsena, Nipan
    Rerknimitr, Rungsun
    Treeprasertsuk, Sombat
    Chaiteerakij, Roongruedee
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1141 - S1141
  • [15] Research progress and prospects of circulating tumor cells in hepatocellular carcinoma
    Li, Chang -Can
    Yang, Hua-Yu
    Mao, Yi-Lei
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2022, 21 (06) : 514 - 515
  • [16] Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma
    Thaninee Prasoppokakorn
    Areeya Buntho
    Praewphan Ingrungruanglert
    Thodsawit Tiyarattanachai
    Tassanan Jaihan
    Kittipat Kulkraisri
    Darlene Ariyaskul
    Chonlada Phathong
    Nipan Israsena
    Rungsun Rerknimitr
    Sombat Treeprasertsuk
    Roongruedee Chaiteerakij
    [J]. Scientific Reports, 12
  • [17] Research progress and prospects of circulating tumor cells in hepatocellular carcinoma
    Chang-Can Li
    Hua-Yu Yang
    Yi-Lei Mao
    [J]. Hepatobiliary & Pancreatic Diseases International, 2022, 21 (06) : 514 - 515
  • [18] Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma
    Prasoppokakorn, Thaninee
    Buntho, Areeya
    Ingrungruanglert, Praewphan
    Tiyarattanachai, Thodsawit
    Jaihan, Tassanan
    Kulkraisri, Kittipat
    Ariyaskul, Darlene
    Phathong, Chonlada
    Israsena, Nipan
    Rerknimitr, Rungsun
    Treeprasertsuk, Sombat
    Chaiteerakij, Roongruedee
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [19] Circulating Tumor DNA and Hepatocellular Carcinoma
    Yang, Ju Dong
    Liu, Minetta C.
    Kisiel, John B.
    [J]. SEMINARS IN LIVER DISEASE, 2019, 39 (04) : 452 - 462
  • [20] Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma
    Temraz, Sally
    Nasr, Rihab
    Mukherji, Deborah
    Kreidieh, Firas
    Shamseddine, Ali
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2022, 22 (05) : 507 - 518
12345